Kingsview Wealth Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History
Bought
Maintained
Sold
Other funds holding BTAL
TAF
FDCDDQ
CWG
OIA
SC
Kingsview Wealth Management's BTAL Position: Q3 2024 in Review
Kingsview Wealth Management sold out of AGF US Market Neutral Anti-Beta Fund (BTAL) in Q3 2024, closing a stake of 13,262 shares — an estimated $260K sold.
Kingsview Wealth Management first reported a position in BTAL in Q4 2018 and held it in 11 quarters. The position peaked at $2.49M in Q2 2020. 71 funds tracked by Wall St. Rank hold BTAL as of Q3 2024.
- Kingsview Wealth Management reported no remaining AGF US Market Neutral Anti-Beta Fund position as of Q3 2024 after selling out during the quarter.
- Kingsview Wealth Management sold 13,262 AGF US Market Neutral Anti-Beta Fund shares in Q3 2024, an estimated $260K.
- Kingsview Wealth Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2018 and held it in 11 quarters.
- Kingsview Wealth Management's AGF US Market Neutral Anti-Beta Fund position peaked at $2.49M in Q2 2020.
- 71 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q3 2024.
Based on Kingsview Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.